Table 2.
Sensitivity rate of Acinetobacter baumannii isolated from sputum and BALF to commonly used antibiotics
| Antibiotics | 2013–2015 | 2016–2018 | ||||
|---|---|---|---|---|---|---|
| BALF | sputum | P | BALF | sputum | P | |
| Piperacillin | 25.8 | 7.9 | P < 0.01 | 2.2 | 2.3 | P > 0.05 |
| Cefoperazone/sulbactam | 14.1 | 17.8 | P > 0.05 | 9.3 | 6.1 | 0.01 < P < 0.05 |
| Ampicillin/sulbactam | 14.2 | 16.7 | P > 0.05 | 9.3 | 5.7 | 0.01 < P < 0.05 |
| Piperacillin/tazobactam | 32.1 | 14.8 | P < 0.01 | 7.1 | 4 | 0.01 < P < 0.05 |
| Ceftazidime | 27.1 | 8.4 | P < 0.01 | 4.8 | 3.1 | P > 0.05 |
| Cefepime | 32.1 | 16.6 | P < 0.01 | 9 | 5.2 | P < 0.01 |
| Aztreonam | 0.6 | 1.5 | P > 0.05 | 0.6 | 0.2 | P > 0.05 |
| Imipenem | 11 | 16.9 | P > 0.05 | 9.6 | 5.5 | P < 0.01 |
| Meropenem | 10.9 | 15.8 | P > 005 | 9.3 | 5 | P < 0.01 |
| Amikacin | 12.8 | 21.4 | 0.01 < P < 0.05 | 14.7 | 10 | 0.01 < P < 0.05 |
| Gentamicin | 9.6 | 14.8 | P > 0.05 | 9.6 | 5.5 | P < 0.01 |
| Tobramycin | 10.9 | 18.1 | 0.01 < P < 0.05 | 12.8 | 7.5 | P < 0.01 |
| Ciprofloxacin | 15.4 | 17.4 | P > 0.05 | 8.3 | 4.7 | P < 0.01 |
| Levofloxacin | 31.4 | 18.2 | P < 0.01 | 9 | 5 | P < 0.01 |
| Trimethoprim sulfamethoxazole | 33.3 | 16.7 | P < 0.01 | 10.3 | 6.7 | 0.01 < P < 0.05 |
| Minocycline | 38.7 | 33.8 | P > 0.05 | 33.4 | 35.3 | P > 0.05 |
| Tegacycline | 34.8 | 46.3 | P < 0.01 | 43.4 | 46.4 | P > 0.05 |